Intelligent Bio Solutions Inc.
$2.93
▼
-11.86%
2026-04-21 07:30:01
ibs.inc
NCM: INBS
Explore Intelligent Bio Solutions Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$5.86 M
Current Price
$2.93
52W High / Low
$24.9 / $2.42
Stock P/E
—
Book Value
$8.96
Dividend Yield
—
ROCE
-359.62%
ROE
-1.5%
Face Value
—
EPS
$-14.45
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
53
Beta
4.59
Debt / Equity
17.67
Current Ratio
2.38
Quick Ratio
0.65
Forward P/E
7.03
Price / Sales
1.37
Enterprise Value
$4.93 M
EV / EBITDA
-0.5
EV / Revenue
1.38
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 2. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 3. | Cytek Biosciences, Inc. | $4.57 | — | $592.62 M | — | -10.52% | -18.05% | $6.18 / $2.37 | $2.66 |
| 4. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 5. | Myomo, Inc. | $0.9 | — | $34.65 M | — | -47.54% | -86.24% | $4.99 / $0.6 | $0.3 |
| 6. | Outset Medical, Inc. | $4.61 | — | $84.32 M | — | -29.4% | -1.06% | $21.98 / $3 | $6.99 |
| 7. | Tivic Health Systems, Inc. | $1.13 | — | $3.25 M | — | -25.51% | -82.69% | $13.23 / $0.72 | $6.65 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0.9 M | 1.11 M | 0.84 M | 0.73 M | 0.61 M | — |
| Operating Profit | -2.61 M | -2.74 M | -2.88 M | -2.55 M | -2.26 M | — |
| Net Profit | -2.68 M | -2.98 M | -3.09 M | -2.54 M | -2.25 M | — |
| EPS in Rs | -1.34 | -1.49 | -1.54 | -1.27 | -1.12 | -7 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.05 M | 3.11 M | 1.26 M | 0 M |
| Operating Profit | -10.42 M | -10.28 M | -8.44 M | -8.34 M |
| Net Profit | -10.57 M | -10.16 M | -10.63 M | -8.31 M |
| EPS in Rs | -5.28 | -5.08 | -5.31 | -4.15 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 8.25 M | 13.78 M | 10.35 M | 12.35 M |
| Total Liabilities | 5.44 M | 5.6 M | 6.67 M | 5.81 M |
| Equity | 3 M | 8.33 M | 3.8 M | 6.62 M |
| Current Assets | 4.14 M | 8.53 M | 3.86 M | 10.87 M |
| Current Liabilities | 5.35 M | 5.45 M | 5.88 M | 4.66 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -9.68 M | -9.57 M | -7.38 M | -3.36 M |
| Investing CF | -0.23 M | -0.22 M | -0.69 M | -0.88 M |
| Financing CF | 4.6 M | 14.56 M | 1.44 M | 0 M |
| Free CF | -9.91 M | -9.79 M | -7.88 M | -3.74 M |
| Capex | -0.23 M | -0.22 M | -0.51 M | -0.38 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 147.58% | — | — | — |
| Earnings Growth % | 4.47% | -28% | — | — |
| Profit Margin % | -326.4% | -845.89% | — | — |
| Operating Margin % | -330.46% | -671.23% | — | — |
| Gross Margin % | 45.81% | 25.99% | — | — |
| EBITDA Margin % | -283.14% | -753.8% | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2025-12-16 | 1:0.1 |
| 2024-01-29 | 1:0.0833333 |
| 2023-02-10 | 1:0.05 |